Does the microbiota regulate immune responses outside the gut?

Trends in Microbiology

Volumn 12, Issue 12, 2004, Pages 562-568

  Noverr, Mairi C ^a   Huffnagle, Gary B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIBIOTIC AGENT; CEFOPERAZONE; PREBIOTIC AGENT; PROBIOTIC AGENT;

ALLERGIC REACTION; ASTHMA; BACTERIAL COLONIZATION; CANDIDA ALBICANS; CLINICAL TRIAL; DIET; ENVIRONMENTAL FACTOR; FOOD COMPOSITION; FUNGUS; GASTROINTESTINAL TRACT; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFANT FEEDING; INTESTINE; INTESTINE FLORA; LACTIC ACID BACTERIUM; LIFESTYLE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SUPPLEMENTATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; FOOD HYPERSENSITIVITY; HUMANS; IMMUNITY; INTESTINAL MUCOSA; INTESTINES; PROBIOTICS;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; FUNGI; MICROBIOTA;

EID: 7944231342     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tim.2004.10.008     Document Type: Review

References (68)

1. M. Wills-Karp The germless theory of allergic disease: revisiting the hygiene hypothesis Nat. Rev. Immunol. 1 2001 69 75
2. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC Lancet 351 1998 1225 1232
3. J.S. Alm Atopy in children of families with an anthroposophic lifestyle Lancet 353 1999 1485 1488
4. K. Wickens Antibiotic use in early childhood and the development of asthma Clin. Exp. Allergy 29 1999 766 771
5. B. Bjorksten The intestinal microflora in allergic Estonian and Swedish 2-year-old children Clin. Exp. Allergy 29 1999 342 346
6. M. Kalliomaki Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing J. Allergy Clin. Immunol. 107 2001 129 134
7. P.V. Kirjavainen Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease FEMS Immunol. Med. Microbiol. 32 2001 1 7
8. B. Bjorksten Allergy development and the intestinal microflora during the first year of life J. Allergy Clin. Immunol. 108 2001 516 520
9. I. Adlerberth Intestinal colonization with Enterobacteriaceae in Pakistani and Swedish hospital-delivered infants Acta Paediatr. Scand. 80 1991 602 610
10. A.J. Macpherson, and N.L. Harris Opinion: Interactions between commensal intestinal bacteria and the immune system Nat. Rev. Immunol. 4 2004 478 485
11. J. Xu Message from a human gut symbiont: sensitivity is a prerequisite for sharing Trends Microbiol. 12 2004 21 28
12. L.V. Hooper Bacterial contributions to mammalian gut development Trends Microbiol. 12 2004 129 134
13. J.D. Taurog The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats J. Exp. Med. 180 1994 2359 2364
14. R.K. Sellon Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect. Immun. 66 1998 5224 5231
15. B.S. Drasar Some factors associated with geographical variations in the intestinal microflora Soc. Appl. Bacteriol. Symp. Ser. 3 1974 187 196
16. B.S. Drasar The relation between diet and the gut microflora in man Proc. Nutr. Soc. 32 1973 49 52
17. A.C. Ouwehand Differences in Bifidobacterium flora composition in allergic and healthy infants J. Allergy Clin. Immunol. 108 2001 144 145
18. J.S. Alm An anthroposophic lifestyle and intestinal microflora in infancy Pediatr. Allergy Immunol. 13 2002 402 411
19. I.S. Farooqi, and J.M. Hopkin Early childhood infection and atopic disorder Thorax 53 1998 927 932
20. M.C. Moreau, and G. Corthier Effect of the gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice Infect. Immun. 56 1988 2766 2768
21. N. Sudo The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction J. Immunol. 159 1997 1739 1745
22. P. McGuirk, and K.H. Mills Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases Trends Immunol. 23 2002 450 455
23. T. Yamanaka Microbial colonization drives lymphocyte accumulation and differentiation in the follicle-associated epithelium of Peyer's patches J. Immunol. 170 2003 816 822
24. T. von der Weid Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10 Clin. Diagn. Lab. Immunol. 8 2001 695 701
25. H.R. Christensen Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells J. Immunol. 168 2002 171 178
26. N. Sudo An oral introduction of intestinal bacteria prevents the development of a long-term Th2-skewed immunological memory induced by neonatal antibiotic treatment in mice Clin. Exp. Allergy 32 2002 1112 1116
27. S.L. Constant Site of antigen delivery can influence T cell priming: pulmonary environment promotes preferential Th2-type differentiation Eur. J. Immunol. 30 2000 840 847
28. K. Takabayashi Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice J. Immunol. 170 2003 3898 3905
29. G. Hall Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production Vaccine 21 2003 549 561
30. X. Zhang Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration J. Immunol. 167 2001 4245 4253
31. M. Russo Prevention of lung eosinophilic inflammation by oral tolerance Immunol. Lett. 61 1998 15 23
32. X.M. Wu Selective suppression of antigen-specific Th2 cells by continuous micro-dose oral tolerance Eur. J. Immunol. 28 1998 134 142
33. J.E. Eyles Tissue distribution of radioactivity following intranasal administration of radioactive microspheres J. Pharm. Pharmacol. 53 2001 601 607
34. D.S. Southam Distribution of intranasal instillations in mice: effects of volume, time, body position, and anesthesia Am. J. Physiol. Lung Cell. Mol. Physiol. 282 2002 L833 L839
35. T.E. Pickett In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors Infect. Immun. 68 2000 205 213
36. M.C. Noverr Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins Infect. Immun. 69 2001 2957 2963
37. M.C. Noverr Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes Clin. Microbiol. Rev. 16 2003 517 533
38. B. Fogelmark Inhalation of (1→3)-beta-D-glucan causes airway eosinophilia Mediators Inflamm. 10 2001 13 19
39. Noverr, M.C. et al. The development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen and IL-13. Infect. Immun. (in press)
40. M.C. Noverr Role of antibiotics and fungal microbiota in driving pulmonary allergic responses Infect. Immun. 72 2004 4996 5003
41. J.M. Saavedra, and A. Tschernia Human studies with probiotics and prebiotics: clinical implications Br. J. Nutr. 87 Suppl. 2 2002 S241 S246
42. L.J. Fooks, and G.R. Gibson Probiotics as modulators of the gut flora Br. J. Nutr. 88 Suppl. 1 2002 S39 S49
43. M. Kalliomaki Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial Lancet 357 2001 1076 1079
44. M. Kalliomaki Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial Lancet 361 2003 1869 1871
45. E. Isolauri Probiotics in the management of atopic eczema Clin. Exp. Allergy 30 2000 1604 1610
46. P.V. Kirjavainen Probiotic bacteria in the management of atopic disease: underscoring the importance of viability J. Pediatr. Gastroenterol. Nutr. 36 2003 223 227
47. P.V. Kirjavainen Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut 51 2002 51 55
48. K. Laiho Probiotics: on-going research on atopic individuals Br. J. Nutr. 88 Suppl 1 2002 S19 S27
49. V. Rosenfeldt Effect of probiotic Lactobacillus strains in children with atopic dermatitis J. Allergy Clin. Immunol. 111 2003 389 395
50. T. Matsuzaki The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice J. Dairy Sci. 81 1998 48 53
51. A. Sullivan Effect of antimicrobial agents on the ecological balance of human microflora Lancet Infect. Dis. 1 2001 101 114
52. T. Hoverstad Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects Scand. J. Gastroenterol. 21 1986 621 626
53. G.W. Tannock Analysis of the intestinal microflora using molecular methods Eur. J. Clin. Nutr. 56 Suppl 4 2002 S44 S49
54. R. Dubos Man Adapting 1971 Yale University Press
55. R. Dubos The effect of antibacterial drugs on the fecal flora of mice J. Exp. Med. 117 1963 231 243
56. G.R. Gibson, and D.C. Collins Concept of balanced colonic micriobiota, prebiotics, and synbiotics L.A. Hanson R.H. Yolken Probiotics, Other Nutritional Factors, and Intestinal Microflora Vol. 42 1999 Lippincott-Raven 139 156
57. H. Tissier Repartition des microbes dans l'infection intestinale chez le nourrisson Ann. Inst. Pasteur Microbiol. 14 1905 109 123
58. S. Fanaro Intestinal microflora in early infancy: composition and development Acta Paediatr. Suppl. 91 2003 48 55
59. R.A. Calderone Candida and Candidiasis 2001 ASM Press
60. R.G. Nair The effect of oral bacteria on Candida albicans germ-tube formation APMIS 109 2001 147 154
61. R.D. Wagner Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice Infect. Immun. 65 1997 4165 4172
62. Noverr, M.C. and Huffnagle, G.B. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect. Immun. (in press)
63. G.A. Bohmig n-butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids Immunology 92 1997 234 243
64. K.A. Hoberg Inhibitory effect of cerulenin and sodium butyrate on germination of Candida albicans Antimicrob. Agents Chemother. 24 1983 401 408
65. H. Hove Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose Am. J. Clin. Nutr. 59 1994 74 79
66. R.E. Leakey The origin of humankind 1994 Basic Books
67. G. Molin Probiotics in foods not containing milk or milk constituents, with special reference to Lactobacillus plantarum 299v Am. J. Clin. Nutr. 73 Suppl. 2 2001 380S 385S
68. G.W. Tannock Analysis of the fecal microflora of human subjects consuming a probiotic product containing Lactobacillus rhamnosus DR20 Appl. Environ. Microbiol. 66 2000 2578 2588